August 29th 2025
August 22nd 2025
Low-dose methylprednisolone is as effective as high-dose for severe pediatric MPP and has fewer side effects, supporting safer treatment strategies.
August 12th 2025
Brensocatib was granted FDA priority review in February 2025 for the small molecule, oral, reversible inhibitor.
August 6th 2025
Pediatric experts emphasize the importance of asthma action plans, medication readiness, and school-based support to help children with asthma stay healthy and active during the academic year.
July 23rd 2025
Can you guess the diagnosis?